Akkermansia and Weight Maintenance

计划入组 90 人 · 首次发布于 2022 年 6 月 14 日

Intestinal Akkermansia Muciniphila in Prostate Cancer

计划入组 52 人 · 首次发布于 2024 年 2 月 5 日

Safety and Tolerability Evaluation of Akkermansia Muciniphila

计划入组 108 人 · 首次发布于 2024 年 12 月 11 日

Oncobax-AK

Orphanin antagonists (The GI company)

UC1MT (Biohaven Pharmaceutical Holding Company/University of Connecticut)

The Akkermansia Company

Belgium

The Medicines Company

United States

KOWA COMPANY LTD

Indonesia

Biotalys Appoints Luc Van Fraeyenhoven as CFO to Lead Financial Strategy During Product Commercialization Phase

Precision Biotics Market Poised to Reach $17.46 Billion by 2035, Driven by Microbiome Science and AI-Powered Discovery

HealthBiome Achieves Dual Regulatory Approval for Akkermansia-Based Muscle Health Ingredient